skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Allogeneic Melanoma Vaccine AGI-101H (Code C78861)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Allogeneic Melanoma Vaccine AGI-101H

Definition: A cancer vaccine derived from two gentically modified human melanoma cell lines with potential antineoplastic activity. Allogeneic melanoma vaccine AGI-101H consists of a 1:1 mixture of cells from two genetically modified human melanoma cell lines, designated as Mich1H6 and Mich2H6, that have been gamma-irradiated to render the cells non-proliferative. Upon administration, this vaccine may stimulate a cytotoxic immune response against melanoma tumor cells.

Label: Allogeneic Melanoma Vaccine AGI-101H

NCI Thesaurus Code: C78861 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL387596  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
AGI-101H
Allogeneic Melanoma Vaccine AGI-101H

External Source Codes: 
PDQ Closed Trial Search ID 601981
PDQ Open Trial Search ID 601981 (check for NCI PDQ open clinical trial info)
NCI META CUI CL387596

Other Properties:
     Name Value (qualifiers indented underneath)
code C78861
Legacy_Concept_Name Allogeneic_Melanoma_Vaccine_AGI-101H
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78861

Mainbox Bottom